Abstract

BackgroundAntiphospholipid Syndrome (APS) is a multisystemic autoimmune disease characterized by arterial and venous thrombosis and / or obstetric morbidity in the presence of at least one circulating anti-phospholipid antibody. The spectrum of vascular events varies from deep venous thrombosis to catastrophic APS, a rare form characterized by acute multiorgan thrombosis and high mortality.Case reportWe present the case of a 32-week pregnant woman arriving in the hospital emergency room with bilateral acute lower limb ischemia. In the obstetric evaluation, fetal death was declared. Computerized Tomography angiography showed pulmonary embolism of both pulmonary arteries, areas of splenic and right renal infarction and multiple arterial and venous thrombosis. The patient underwent urgent caesarean section and axillary-bifemoral bypass. No events registered. In the postoperative period, in an intensive care unit, treatment with rituximab and plasmapheresis were added to anticoagulant therapy. The laboratorial investigation was negative for thrombophilia and autoimmune diseases.ConclusionCatastrophic APS develops quickly, with multiorgan involvement and high mortality rate. The presented case poses a multidisciplinary challenge, with the surgical approach of extra-anatomical revascularization being less invasive and guaranteeing immediate perfusion of the lower limbs. Although the serological tests were negative for anti-phospholipid antibodies, this case hardly fits into another diagnosis. Therefore, it was treated as a catastrophic APS, having shown a favorable evolution.

Highlights

  • Pregnancy is characterized by a hypercoagulable state which confers protection against hemorrhagic challenges such as childbirth or miscarriage

  • Renal involvement is defined by a 50% rise in serum creatinine, severe systemic hypertension (> 180/100 mmHg) and/or proteinuria (> 500 mg/24 h) b For histopathological confirmation, significant evidence of thrombosis must be present, vasculitis may coexist occasionally c If the patient had not been previously diagnosed as having an Antiphospholipid Syndrome (APS), the laboratory confirmation requires that presence of antiphospholipid antibodies must be detected on two or more occasions at least 6 weeks apart, according to the proposed preliminary criteria for the classification of definite APS

  • catastrophic APS (CAPS) is a rare form of APS that develops quickly, with multiorgan involvement, high mortality rate, and its approach often poses a multidisciplinary challenge

Read more

Summary

Introduction

Pregnancy is characterized by a hypercoagulable state which confers protection against hemorrhagic challenges such as childbirth or miscarriage. APS is a systemic autoimmune disorder (AID) characterized by recurrent arterial or venous thrombosis and/ or pregnancy morbidity (fetal loss and stillbirth) in the presence of anti-phospholipid (aPL) antibodies, typically lupus anticoagulant (LA), anticardiolipin (aCL) or antiβ glycoprotein-I (β2GPI) [2,3,4,5,6]. Antiphospholipid Syndrome (APS) is a multisystemic autoimmune disease characterized by arterial and venous thrombosis and / or obstetric morbidity in the presence of at least one circulating anti-phospholipid antibody. The spectrum of vascular events varies from deep venous thrombosis to catastrophic APS, a rare form characterized by acute multiorgan thrombosis and high mortality. The laboratorial investigation was negative for thrombophilia and autoimmune diseases

Objectives
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call